Amoxicillin Clavulanate 875/125mg Tablets

Amoxicillin and Clavulanate Tablets
  • Dosage: Amoxicillin and Clavulanate 875/125
  • Packaging: 10tablets/blister*10/box
  • Shelf Life: 36months 

Click to add this item to cart.

Product Description

Product NameAmoxicillin and Clavulanate Tablets (Amoxicillin 875mg + Clavulanate 125mg Oral Tablets)
SpecificationEach tablet contains: Amoxicillin 875mg (as Amoxicillin Trihydrate) + Clavulanic Acid 125mg (as Clavulanate Potassium)
Dosage FormOral Film-Coated Tablet (for oral administration)
Active IngredientsAmoxicillin / Clavulanic Acid (Clavulanate Potassium)
Pharmacological ClassBeta-Lactam Antibiotic + Beta-Lactamase Inhibitor Combination
Route of AdministrationOral administration (swallowed whole with water). Take at the start of a meal to minimize gastrointestinal intolerance and improve absorption.
PackagingBlister pack (PVC-Alu) or HDPE bottle, typically 10 or 14 tablets per blister pack or bottle
StorageStore below 25°C, in a dry place, protected from light and moisture. Keep container tightly closed. Do not freeze.
Shelf Life36 months (unopened)

Product Overview

Amoxicillin and Clavulanate Tablets is an oral combination antibiotic preparation containing Amoxicillin 875mg and Clavulanic Acid 125mg per film-coated tablet. Amoxicillin is a broad-spectrum beta-lactam antibiotic, while clavulanic acid is a beta-lactamase inhibitor that protects amoxicillin from degradation by beta-lactamase enzymes produced by certain resistant bacteria. This 875/125mg strength (14:1 ratio) is the standard adult formulation, typically dosed twice daily.

Amoxicillin Clavulanate 875/125mg Tablets: What the Published Guidance Says

A broad portfolio spanning the WHO Access and Watch groups, supplied with the documentation that stewardship programmes and national tenders require.

Amoxicillin Clavulanate 875/125mg Tablets sits in the Antibacterials range. The notes below are the ones that most often change a specification, a label or a tender submission.

  • WHO's own indication mapping is public — we align to it The WHO Antibiotics Portal lists amoxicillin as first choice for community-acquired pneumonia (mild to moderate), acute otitis media, acute sinusitis, acute pharyngitis and uncomplicated acute malnutrition in children; amoxicillin + clavulanic acid as first choice for severe community-acquired pneumonia in children, hospital-acquired pneumonia, cystitis and cellulitis; and ceftriaxone as first choice for severe acute pyelonephritis. WHO Antibiotics Portal — AWaRe
  • Access group — the empirical workhorses The WHO AWaRe classification places amoxicillin, amoxicillin + clavulanic acid, ampicillin, clindamycin, gentamicin, metronidazole, chloramphenicol and doxycycline in the Access group. These are the medicines expected to be available in every functioning health system. WHO AWaRe (Access, Watch, Reserve) classification of antibiotics
  • AWaRe is the framework buyers and stewards now work to WHO's AWaRe classification divides antibiotics into Access, Watch and Reserve. Access agents are described as those that should be widely available, affordable and quality-assured to improve access and promote appropriate use. Watch agents carry higher resistance potential and should be prioritised as targets of stewardship programmes and monitoring. WHO Antibiotics Portal — AWaRe

We quote these sources rather than paraphrase them loosely, because the detail matters commercially for Amoxicillin Clavulanate 875/125mg Tablets. Where your national list differs from the WHO listing, the national list governs what may be supplied and promoted locally.

Amoxicillin Clavulanate 875/125mg Tablets — Supply Parameters

Product NameAmoxicillin and Clavulanate Tablets (Amoxicillin 875mg + Clavulanate 125mg Oral Tablets)
SpecificationEach tablet contains: Amoxicillin 875mg (as Amoxicillin Trihydrate) + Clavulanic Acid 125mg (as Clavulanate Potassium)
Dosage FormOral Film-Coated Tablet (for oral administration)
Active IngredientsAmoxicillin / Clavulanic Acid (Clavulanate Potassium)
Pharmacological ClassBeta-Lactam Antibiotic + Beta-Lactamase Inhibitor Combination
Route of AdministrationOral administration (swallowed whole with water). Take at the start of a meal to minimize gastrointestinal intolerance and improve absorption.
StorageStore below 25°C, in a dry place, protected from light and moisture. Keep container tightly closed. Do not freeze.
Therapeutic groupAntibacterials — Antibacterials
ManufacturerSinophare Bio-technology Co., Ltd. (GMP, China)
Documentation suppliedCOA, HPLC/GC data, stability data, dossier package

The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Ciprofloxacin 500mg Tablets, Amoxicillin Chewable Tablets 400mg, Amoxicillin Clavulanate 400/57mg Chewable Tablets, Azithromycin 500mg Tablets, Metronidazole Tablets 500mg, Ampicillin 500mg Capsules, Azithromycin 400mg Capsules, Clarithromycin 250mg Capsules.

Quality Control, Pharmacopoeial Standards & Documentation

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Every batch of Amoxicillin Clavulanate 875/125mg Tablets is tested to the monograph stated on the purchase order. Where a monograph is silent on the presentation, we agree a written specification with you in advance and reference it on the certificate of analysis.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

A typical release panel for this presentation covers:

  • Testing for heavy metals and elemental impurities
  • Testing for packaging integrity and seal testing
  • Testing for description and identification
  • Testing for assay of the active substance
  • Testing for related substances and impurities
  • Testing for dissolution or release profile (solid oral forms)

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

Packaging, Labelling & Export

  • Pack size: Blister pack (PVC-Alu) or HDPE bottle, typically 10 or 14 tablets per blister pack or bottle. Non-standard pack sizes can be quoted against your artwork.
  • Storage: Store below 25°C, in a dry place, protected from light and moisture. Keep container tightly closed. Do not freeze..
  • Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
  • Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
  • Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.

Registration, Dossier & Tender Support

Documents for Amoxicillin Clavulanate 875/125mg Tablets are issued by Sinophare Bio-technology Co., Ltd. — DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. Keeping one legal manufacturer across the COA, the GMP certificate and the registration file avoids assessment queries later.

  • CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
  • Site Master File and GMP certificate for the manufacturing workshops.
  • Method validation, stability protocol and the shelf-life justification for the marketed pack.
  • Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
  • Tender and framework documentation, including pre-qualification questionnaires and sample logistics.

The context for Amoxicillin Clavulanate 875/125mg Tablets is its place among antibacterials classified in the WHO AWaRe framework. Listing status informs how programmes specify a product; it is not a substitute for the import licence or marketing authorisation of the destination country.

Frequently Asked Questions

What pack size is available for Amoxicillin Clavulanate 875/125mg Tablets?

This presentation is normally supplied as Blister pack (PVC-Alu) or HDPE bottle, typically 10 or 14 tablets per blister pack or bottle. Where your market requires a different count, bottle or carton, we quote to your artwork and extend the stability file to the new pack.

What documentation comes with a shipment of Amoxicillin Clavulanate 875/125mg Tablets?

Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 36 months.

Does the batch documentation for Amoxicillin Clavulanate 875/125mg Tablets support a registration filing?

Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.

Which of your antibiotics are in the WHO Access group?

Amoxicillin, amoxicillin + clavulanic acid, ampicillin, clindamycin, gentamicin, metronidazole and chloramphenicol are classified in the Access group under the WHO AWaRe classification.

Can you supply sterile injectable antibiotics with endotoxin data?

Yes. Injectable products are supplied with sterility and bacterial endotoxin results included on the batch certificate of analysis, alongside assay and related-substances data.

Related Antibacterials Products

Browse the full Antibacterials range; all Tablets; the complete product catalogue.

Request a Quotation for Amoxicillin Clavulanate 875/125mg Tablets

For tenders and programme supply, send the line item, pack size, quantity and destination for Amoxicillin Clavulanate 875/125mg Tablets 875mg. We return a quotation with lead time, documentation list and sample availability in one response.

Request a quotation

Sources & Regulatory Notes

Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.

<< return to products